Literature DB >> 2180975

Impact of obesity on insulin action in volunteers with normal glucose tolerance: demonstration of a threshold for the adverse effect of obesity.

P J Campbell1, J E Gerich.   

Abstract

We examined whether obesity must first exceed a critical threshold before it begins to impair insulin action in volunteers with normal glucose tolerance. Forty-nine healthy volunteers, whose ideal body weight ranged from 80-240%, underwent euglycemic clamps during sequential insulin infusions of 0.4, 1.0, and 10 mU/kg.min. Insulin sensitivity was assessed by estimation of the plasma insulin concentration that produced half-maximal glucose disposal (EC50). Glucose disposal during the highest insulin infusion was used as an index of maximal insulin responsiveness. There was a significant correlation between body mass index and insulin sensitivity (EC50) best fitted by a straight line that broke at a body mass index of 26.8 kg/m2 (P less than 0.05). Below this breakpoint (26.8 kg/m2), there was no significant correlation (r = 0.1), whereas above the breakpoint there was a strong positive correlation (r = 0.8; P less than 0.001) between EC50 and body mass index. In contrast, insulin responsiveness was not significantly correlated with body mass index (r = 0.1). We conclude that insulin sensitivity for glucose disposal is impaired in human subjects with normal glucose tolerance who exceed a critical threshold of obesity, which corresponds to an ideal body weight of 120%. This threshold is consistent with the nonlinear (J-shaped) relationship between obesity and its other adverse health consequences, and may have important implications for desirable weight goals.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2180975     DOI: 10.1210/jcem-70-4-1114

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

1.  A genome scan for loci linked to quantitative insulin traits in persons without diabetes: the Framingham Offspring Study.

Authors:  J H O van Tilburg; C Wijmenga; T W van Haeften
Journal:  Diabetologia       Date:  2003-10-24       Impact factor: 10.122

2.  Effect of long-term strength training on glucose metabolism. Implications for individual impact of high lean mass and high fat mass on relationship between BMI and insulin sensitivity.

Authors:  A Gippini; A Mato; R Pazos; B Suarez; B Vila; P Gayoso; M Lage; F F Casanueva
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

Review 3.  Reporting weight loss 2007.

Authors:  Mervyn Deitel; Khaled Gawdat; John Melissas
Journal:  Obes Surg       Date:  2007-05       Impact factor: 4.129

4.  Ovarian steroids modulate neuroendocrine dysfunction in polycystic ovary syndrome.

Authors:  S A R Doi; M Al-Zaid; P A Towers; C J Scott; K A S Al-Shoumer
Journal:  J Endocrinol Invest       Date:  2005-11       Impact factor: 4.256

5.  Failure to adequately adapt reduced insulin sensitivity with increased insulin secretion in women with impaired glucose tolerance.

Authors:  H Larsson; B Ahrén
Journal:  Diabetologia       Date:  1996-09       Impact factor: 10.122

Review 6.  Primary, secondary and tertiary prevention of non-insulin-dependent diabetes.

Authors:  A Dornhorst; P K Merrin
Journal:  Postgrad Med J       Date:  1994-08       Impact factor: 2.401

7.  Increased neuronal nitric oxide synthase dimerisation is involved in rat and human pancreatic beta cell hyperactivity in obesity.

Authors:  K Mezghenna; P Pomiès; A Chalançon; F Castex; J Leroy; N Niclauss; B Nadal; L Cambier; C Cazevieille; P Petit; R Gomis; T Berney; R Gross; A D Lajoix
Journal:  Diabetologia       Date:  2011-08-18       Impact factor: 10.122

8.  Increased abundance of the receptor-type protein-tyrosine phosphatase LAR accounts for the elevated insulin receptor dephosphorylating activity in adipose tissue of obese human subjects.

Authors:  F Ahmad; R V Considine; B J Goldstein
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

Review 9.  Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.

Authors:  M P Leondires; S L Berga
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

10.  Prevalence and risk factors for type 2 diabetes mellitus with Prader-Willi syndrome: a single center experience.

Authors:  Aram Yang; Jinsup Kim; Sung Yoon Cho; Dong-Kyu Jin
Journal:  Orphanet J Rare Dis       Date:  2017-08-30       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.